Newsroom

Sorted by: Latest

-

LP Building Solutions Breaks Ground on New LP® SmartSide® ExpertFinish® Manufacturing Facility in North Branch, Minnesota

NASHVILLE, Tenn.--(BUSINESS WIRE)--LP Building Solutions (LP), a leading manufacturer of high-performance building products, broke ground on a new LP® SmartSide® ExpertFinish® Trim & Siding manufacturing facility today in North Branch, Minnesota. The approximately 350,000-square-foot facility will be built on a recently acquired 120-acre site. It is expected to create 125 jobs at full capacity and is slated to begin production in the first quarter of 2028. “This investment reflects the stro...
-

Bacardi acquiert la totalité du capital du whisky irlandais TEELING®

HAMILTON, Bermudes--(BUSINESS WIRE)--Bacardi Limited a annoncé la finalisation d’une transaction qui fait de cette entreprise familiale l’unique propriétaire de la Teeling Whiskey Company et de la marque de whisky irlandais TEELING®. Les fondateurs, Jack et Stephen Teeling, resteront associés à la marque, contribuant à façonner son avenir et à stimuler sa croissance à long terme en tant que conseillers stratégiques. L’annonce d’aujourd’hui fait suite à la collaboration fructueuse entre les deux...
-

A Bacardi teljes tulajdonjogot szerez a TEELING® ír whisky felett

HAMILTON, Bermuda--(BUSINESS WIRE)--A Bacardi Limited bejelentette annak a tranzakciónak a lezárását, amely a családi tulajdonban lévő vállalatot a Teeling Whiskey Company és a TEELING® ír whiskymárka egyedüli tulajdonosává teszi. Az alapítók, Jack és Stephen Teeling továbbra is a márka részesei maradnak, stratégiai tanácsadóként alakítják a jövőjét és hosszú távon támogatják a növekedését. A mai bejelentés a két vállalat közötti, 2017-ben indult sikeres kapcsolatot követi, amikor a Bacardi kis...
-

Samenvatting: Veristat versterkt biostatistiek, advies bij ontwikkeling van geneesmiddelen en peoplemanagement om groei in complexe klinische ontwikkeling te ondersteunen

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--VeristatTM, een internationale CRO (Clinical Research Organization) en consultancy gespecialiseerd in complexe studies, maakte vandaag vier aanwervingen van strategische kaderleden bekend ter bevordering van zijn missie om de goedkeuring te versnellen van nieuwe therapieën in de domeinen van complexe ziekten, waaronder cel- en gentherapie, oncologie en zeldzame aandoeningen. Verder bouwend op zijn 30-jarige grondslag in biostatistiek en de recente overname...
-

BerryDunn’s 30th Annual EMPOWER Summit Tackles Issues Facing Nonprofits

PORTLAND, Maine--(BUSINESS WIRE)--BerryDunn, a full-service accounting, tax, and consulting firm, will host its annual Nonprofit Summit, EMPOWER, on Wednesday, June 24, 2026. Continuing a 30-year history of providing education for nonprofit leaders, the half-day virtual summit will focus on current industry trends and practical guidance to help leaders in the nonprofit sector confidently navigate an increasingly complex environment. Presenters at this year’s summit will address funding pressure...
-

Riassunto: Veristat rafforza la biostatistica, la consulenza per lo sviluppo dei farmaci e la leadership delle persone per sostenere la crescita nello sviluppo clinico complesso

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--VeristatTM , organizzazione di ricerca clinica (CRO) internazionale e società di consulenza specializzata in studi complessi, oggi ha annunciato quattro assunzioni strategiche ai vertici aziendali che promuovono la sua missione di accelerare nuove approvazioni terapeutiche nell'ambito di patologie complesse, tra cui citoterapia e terapia genica, oncologia e malattie rare. Grazie alla sua esperienza trentennale nella biostatistica e la sua recente acquisizio...
-

KBRA Assigns Preliminary Ratings to MAPS 2026-2 Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to two classes of notes issued by MAPS 2026-2 Trust (MAPS 2026-2), an aviation ABS transaction. MAPS 2026-2 represents the second aviation ABS transaction serviced by Perseus Asset Management Limited (Perseus, the Servicer, or the Company). It is the fifth aviation lease ABS issued under Apollo’s aviation finance platform, following three prior transactions completed by Merx Aviation (Merx) between 2018 and 2021, and the inaugural tran...
-

Cloudflare y beehiiv presentan controles de rastreo con IA para ayudar a los editores independientes a navegar por la era de la inteligencia artificial

SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), empresa líder en conectividad en la nube, y beehiiv, plataforma de publicación especializada en boletines informativos que ayuda a editores y empresas a gestionar, aumentar y monetizar sus audiencias, acaban de anunciar una alianza estratégica para redefinir la economía de los creadores y la forma en que creadores independientes interactúan con la inteligencia artificial. Esta colaboración, que integra la avanzada tecnología Crawl Co...
-

Legislature and CalCIMA Celebrate 50 Years of Surface Mining and Reclamation Act (SMARA) in California

SACRAMENTO, Calif.--(BUSINESS WIRE)--The California State Assembly Monday approved ACR 157, commemorating the 50th anniversary of the Surface Mining and Reclamation Act (SMARA), the landmark for responsible mineral resource development and land reclamation. Authored by Assemblymember Josh Hoover (R-Folsom) with bipartisan support and co-authorship from Assemblymembers Jasmeet Bains (D-Delano), Stephanie Nguyen (D-Elk Grove) and more than 50 other members, the resolution celebrates five decades...
-

Veristat renforce ses activités en biostatistique, de conseil en développement de médicaments et de gestion des ressources humaines afin de soutenir la croissance dans le développement clinique complexe

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--VeristatTM, une organisation mondiale de recherche clinique sous contrat (CRO) et cabinet de conseil spécialisé dans les études complexes, a annoncé aujourd'hui quatre nominations de dirigeants stratégiques qui contribueront à faire avancer sa mission : accélérer les approbations de nouvelles thérapies dans des domaines de maladies complexes, notamment la thérapie cellulaire et génique, l'oncologie et les maladies rares. S'appuyant sur ses 30 années...